Search alternatives:
point decrease » point increase (Expand Search)
mg decrease » _ decrease (Expand Search), nn decrease (Expand Search), we decrease (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
5 mg » 5 mm (Expand Search)
point decrease » point increase (Expand Search)
mg decrease » _ decrease (Expand Search), nn decrease (Expand Search), we decrease (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
5 mg » 5 mm (Expand Search)
-
19821
Effects of AP-5 application on EPSCs in control and hyperglycemic mice.
Published 2015“…<b>D.</b> Mean percent decrease in mEPSC frequency following application of AP-5 in control (n = 9) and hyperglycemic (n = 10) mice. …”
-
19822
CRISPRi knockdown of Lon protease to increase half-life.
Published 2018“…Bivariate scatter plots show P<sub><i>inaA</i></sub> and P<sub><i>acrAB</i></sub> expression levels at the final time point across n = 5 microcolonies. …”
-
19823
Performance of the intact model.
Published 2015“…At lower values of <i>α</i> two distinct regimes exist: the first has a phase difference between flexor centers less than 0.5 (lower branch) which corresponds to the activation pattern shown in <b>A</b> (LF leads, RF activates on LF’s shutdown, then a pause until LF activates again) and the second regime has a phase difference greater than 0.5 (upper branch) when RF activates first and LF activates on RF’s shutdown (not shown on <b>A</b>). …”
-
19824
Image 2_Huashi Runzao decoction for primary Sjögren disease: a double-blind, randomized controlled trial combined with m6A and m5C RNA modification analysis.tif
Published 2025“…Moreover, HRD increased m6A levels and decreased m5C levels in pSD patients, and HNRNPA2B1 was identified as a potential key epigenetic regulator.…”
-
19825
Image 1_Huashi Runzao decoction for primary Sjögren disease: a double-blind, randomized controlled trial combined with m6A and m5C RNA modification analysis.tif
Published 2025“…Moreover, HRD increased m6A levels and decreased m5C levels in pSD patients, and HNRNPA2B1 was identified as a potential key epigenetic regulator.…”
-
19826
-
19827
Supplementary Material for: Dietary Phosphate Binding and Loading Alter Kidney Angiotensin-Converting Enzyme mRNA and Protein Content in 5/6 Nephrectomized Rats
Published 2012“…Dietary phosphate loading also resulted in lower AT<sub>1a</sub> gene transcription. <i>Conclusion:</i> Dietary phosphate loading was associated with elevated kidney ACE expression, increased tissue damage and lower AT<sub>1a</sub> transcription in 5/6 NX rats. …”
-
19828
Expression of differentiated MM markers in E15.5 embryonic kidneys and E12.5 aggregates after 7 days in culture.
Published 2015“…<p>qRT-PCR results show that, as compared to E12.5 embryonic kidneys, E15.5 embryonic kidneys had a significant decrease in the expression of NPC marker genes (<i>Six2</i>, <i>Eya1</i> and <i>Gdnf</i>) and a significant increase in the expression of differentiated MM cell marker genes (<i>Podxl1</i>, <i>Nkcc2</i>, <i>Slc5a1</i> and <i>Slc12a3</i>) (A, B). …”
-
19829
-
19830
-
19831
-
19832
Comparison of the myogenic response in middle cerebral artery (MCA) isolated from Dusp5 ZFN KO versus FHH.1<sup>BN</sup> and FHH rats.
Published 2014“…The MCA also constricted in Sprague Dawley rats that is widely used as a control strain for the myogenic response. Mean values ± SE are presented. …”
-
19833
-
19834
-
19835
-
19836
-
19837
-
19838
-
19839
Raw data used for graph (related to Fig 1).
Published 2024“…It seems this drug was unable to reduce the expression of <i>MDM2</i> gene significantly in triple negative (MDA-MB-231) cancer cells; however, a decrease was observed in luminal A (MCF-7) cells. …”
-
19840
Trajectories of a population of individuals with strategies for sex ratios of <i>0.2, 0.5</i> and <i>0.8</i> for initial conditions.
Published 2013“…This mechanism is clearly shown in the trajectories of strategy <i>0.5</i>. The trajectory switches from a decrease to an increase when trajectory of passes the trajectory of (see panel <i>b</i>). …”